Terazosin Hydrochloride Anhydrous (Mylan Pharmaceuticals Inc.)
Welcome to the PulseAid listing for the Terazosin Hydrochloride Anhydrous drug offered from Mylan Pharmaceuticals Inc.. This Adrenergic alpha-Antagonists [MoA],alpha-Adrenergic Blocker [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Mylan Pharmaceuticals Inc. |
NON-PROPRIETARY NAME: | terazosin hydrochloride anhydrous |
SUBSTANCE NAME: | TERAZOSIN HYDROCHLORIDE ANHYDROUS |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Adrenergic alpha-Antagonists [MoA],alpha-Adrenergic Blocker [EPC] |
ROUTE: | ORAL |
DOSAGE FORM: | CAPSULE |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2000-02-22 |
END MARKETING DATE: | 0000-00-00 |
Terazosin Hydrochloride Anhydrous HUMAN PRESCRIPTION DRUG Details:
Item Description | Terazosin Hydrochloride Anhydrous from Mylan Pharmaceuticals Inc. |
LABELER NAME: | Mylan Pharmaceuticals Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 10(mg/1) |
START MARKETING DATE: | 2000-02-22 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0378-1570_2ef2542c-d0fa-429d-9c96-cc3273586888 |
PRODUCT NDC: | 0378-1570 |
APPLICATION NUMBER: | ANDA075140 |
Other TERAZOSIN HYDROCHLORIDE ANHYDROUS Pharmaceutical Manufacturers / Labelers: